1. The Efficacy and Safety of a Qiliqiangxin Capsule Combined with Sacubitril/Valsartan in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis
    Wensheng Chen et al, 2023, Evidence-Based Complementary and Alternative Medicine CrossRef
  2. Recent pharmacological advances in the treatment of cardiovascular events with Astragaloside IV
    Zehui Xu et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  3. Effect of Astragaloside IV on improving cardiac function in rats with heart failure: a preclinical systematic review and meta-analysis
    Zhiyuan Zhang et al, 2023, Frontiers in Pharmacology CrossRef
  4. The state of astragaloside IV research: A bibliometric and visualized analysis
    Ning Liu et al, 2024, Fundamental & Clinical Pharmacology CrossRef
  5. Cardioprotective Effects and Mechanisms of Saponins on Cardiovascular Disease
    Xin Ma et al, 2022, Natural Product Communications CrossRef
  6. SUMO-specific protease 1 inhibitors–A literature and patent overview
    Hang Li et al, 2022, Expert Opinion on Therapeutic Patents CrossRef
  7. Natural Products Against Renal Fibrosis via Modulation of SUMOylation
    Peng Liu et al, 2022, Frontiers in Pharmacology CrossRef
  8. The traditional Chinese medicines treat chronic heart failure and their main bioactive constituents and mechanisms
    Jie Chen et al, 2023, Acta Pharmaceutica Sinica B CrossRef
  9. Astragaloside IV for Heart Failure: Preclinical Evidence and Possible Mechanisms, A Systematic Review and Meta-Analysis
    Xing-xing Li et al, 2023, Chinese Journal of Integrative Medicine CrossRef